Kessler Markus, Suzuki Erika, Montgomery Kyle, Arai Amy C
Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL 62702, USA.
Neurochem Int. 2008 Jun;52(8):1383-93. doi: 10.1016/j.neuint.2008.02.009. Epub 2008 Mar 8.
Radioligand binding studies have shown that AMPA receptors exist in two variants that differ about twenty-fold in their binding affinities, with brain receptors being mainly of the low-affinity type and recombinantly expressed receptors having almost exclusively high affinity. However, the physiological correlate of high- and low-affinity binding is not yet known. In this study we examined if physiological experiments similarly reveal evidence for two distinct receptor variants. We therefore measured equilibrium desensitization by glutamate and determined IC(50) values for neuronal receptors and for the homomeric receptors GluR1-4 expressed in HEK293 cells. Contrary to the prediction that these IC(50) values exhibit large differences commensurate with those of high- and low-affinity binding, values for homomeric receptors (1-18 microM) were on an average not different from those of neuronal receptors (3-10 microM). Moreover, simulations with kinetic receptor models suggest that the IC(50) values for neuronal and recombinant receptors correspond to the binding affinity of the low-affinity receptor variant. These findings indicate that the high-affinity binding measured in heterologous expression systems represents an immature receptor variant that does not contribute to the currents recorded from these cells, and that the functional low-affinity receptors are present in such small number that they are effectively masked in binding assays by the high-affinity receptors. Thus, in order to compare experimentally determined saturation binding profiles with those predicted by kinetic receptor models and with dose-response curves from physiological studies, it will be imperative to develop methods for isolating first the low-affinity receptors.
放射性配体结合研究表明,α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体存在两种变体,它们的结合亲和力相差约20倍,脑内受体主要是低亲和力类型,而重组表达的受体几乎全是高亲和力的。然而,高亲和力和低亲和力结合的生理关联尚不清楚。在本研究中,我们检验了生理实验是否同样能揭示两种不同受体变体的证据。因此,我们通过谷氨酸测量了平衡脱敏,并测定了神经元受体以及在人胚肾293(HEK293)细胞中表达的同聚体受体GluR1 - 4的半数抑制浓度(IC50)值。与这些IC50值会呈现出与高亲和力和低亲和力结合的差异相称的巨大差异这一预测相反,同聚体受体的IC50值(1 - 18微摩尔)平均与神经元受体的IC50值(3 - 10微摩尔)并无不同。此外,用动力学受体模型进行的模拟表明,神经元受体和重组受体的IC50值对应于低亲和力受体变体的结合亲和力。这些发现表明,在异源表达系统中测得의高亲和力结合代表了一种未成熟的受体变体,它对这些细胞记录的电流没有贡献,而且功能性低亲和力受体数量极少,以至于在结合试验中它们被高亲和力受体有效地掩盖了。因此,为了将实验测定的饱和结合曲线与动力学受体模型预测的以及生理研究的剂量反应曲线进行比较,开发首先分离低亲和力受体的方法将是必不可少的。